AU Stock MarketDetailed Quotes

CHM Chimeric Therapeutics Ltd

Watchlist
  • 0.018
  • 0.0000.00%
20min DelayNot Open Aug 12 16:00 AET
15.96MMarket Cap-305P/E (Static)

Chimeric Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(FY)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-87.15%2.36M
-87.15%2.36M
-17.98%18.38M
--18.38M
--22.41M
-Cash and cash equivalents
-87.15%2.36M
-87.15%2.36M
-17.98%18.38M
--18.38M
--22.41M
-Accounts receivable
-99.00%26.62K
-99.00%26.62K
10,861.66%2.66M
--2.66M
--24.25K
-Other receivables
103.92%3.41M
103.92%3.41M
67.87%1.67M
--1.67M
--994.88K
Total current assets
-55.83%9.35M
-55.83%9.35M
-6.59%21.17M
--21.17M
--22.67M
Non current assets
-Goodwill
-4.94%12.98M
-4.94%12.98M
-1.25%13.65M
--13.65M
--13.83M
Regulatory assets
150.52%6.66M
150.52%6.66M
10,861.66%2.66M
--2.66M
--24.25K
Liabilities
Current liabilities
-accounts payable
57.47%7.41M
57.47%7.41M
130.78%4.7M
--4.7M
--2.04M
-Total tax payable
1,225.52%2.02M
1,225.52%2.02M
-96.20%152.57K
--152.57K
--4.02M
Current liabilities
62.87%14.69M
62.87%14.69M
22.65%9.02M
--9.02M
--7.35M
Non current liabilities
Non current accrued expenses
-64.97%5.6K
-64.97%5.6K
17.33%15.99K
--15.99K
--13.63K
Preferred securities outside stock equity
126.51%439.34K
126.51%439.34K
211.66%193.96K
--193.96K
--62.24K
Total non current liabilities
82.21%16.71M
82.21%16.71M
-19.35%9.17M
--9.17M
--11.37M
Shareholders'equity
Share capital
4.10%53.93M
4.10%53.93M
38.65%51.81M
--51.81M
--37.37M
-common stock
4.10%53.93M
4.10%53.93M
38.65%51.81M
--51.81M
--37.37M
Gains losses not affecting retained earnings
78.73%8.51M
78.73%8.51M
61.90%4.76M
--4.76M
--2.94M
Other equity interest
151.55%330.57K
151.55%330.57K
-43.02%131.42K
--131.42K
--230.62K
Total equity
-35.85%22.38M
-35.85%22.38M
-4.45%34.88M
--34.88M
--36.5M
(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022(FY)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -87.15%2.36M-87.15%2.36M-17.98%18.38M--18.38M--22.41M
-Cash and cash equivalents -87.15%2.36M-87.15%2.36M-17.98%18.38M--18.38M--22.41M
-Accounts receivable -99.00%26.62K-99.00%26.62K10,861.66%2.66M--2.66M--24.25K
-Other receivables 103.92%3.41M103.92%3.41M67.87%1.67M--1.67M--994.88K
Total current assets -55.83%9.35M-55.83%9.35M-6.59%21.17M--21.17M--22.67M
Non current assets
-Goodwill -4.94%12.98M-4.94%12.98M-1.25%13.65M--13.65M--13.83M
Regulatory assets 150.52%6.66M150.52%6.66M10,861.66%2.66M--2.66M--24.25K
Liabilities
Current liabilities
-accounts payable 57.47%7.41M57.47%7.41M130.78%4.7M--4.7M--2.04M
-Total tax payable 1,225.52%2.02M1,225.52%2.02M-96.20%152.57K--152.57K--4.02M
Current liabilities 62.87%14.69M62.87%14.69M22.65%9.02M--9.02M--7.35M
Non current liabilities
Non current accrued expenses -64.97%5.6K-64.97%5.6K17.33%15.99K--15.99K--13.63K
Preferred securities outside stock equity 126.51%439.34K126.51%439.34K211.66%193.96K--193.96K--62.24K
Total non current liabilities 82.21%16.71M82.21%16.71M-19.35%9.17M--9.17M--11.37M
Shareholders'equity
Share capital 4.10%53.93M4.10%53.93M38.65%51.81M--51.81M--37.37M
-common stock 4.10%53.93M4.10%53.93M38.65%51.81M--51.81M--37.37M
Gains losses not affecting retained earnings 78.73%8.51M78.73%8.51M61.90%4.76M--4.76M--2.94M
Other equity interest 151.55%330.57K151.55%330.57K-43.02%131.42K--131.42K--230.62K
Total equity -35.85%22.38M-35.85%22.38M-4.45%34.88M--34.88M--36.5M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg